Kumpulan Info tentang,
UNIVERSITAS SURABAYA
| No | Source Title | CiteScore | Quartile | Publisher | Highest percentile | Citations 2021-24 | Documents 2021-24 |
|---|---|---|---|---|---|---|---|
| 27091 | Tourism and Hospitality | 3.7 | Q1 | Multidisciplinary Digital Publishing Institute (MDPI) | 80.0% 133/674 Social Sciences (miscellaneous) | 745 | 201 |
| 27092 | China Economic Quarterly International | 3.8 | Q1 | KeAi Communications Co. | 80.0% 129/674 Social Sciences (miscellaneous) | 353 | 93 |
| 27093 | Malaysian Journal of Syariah and Law | 0.9 | Q1 | Faculty of Syariah and Law, Islamic Science University of Malaysia (USIM) | 79.0% 146/705 Religious Studies | 115 | 127 |
| 27094 | European Journal of American Studies | 0.5 | Q1 | European Association for American Studies | 78.0% 248/1160 Literature and Literary Theory | 91 | 177 |
| 27095 | Hasanuddin Law Review | 2.6 | Q1 | Faculty of Law, Universitas Hasanuddin | 78.0% 235/1105 Law | 198 | 77 |
| 27096 | Theranostics | 23.9 | Q1 | Ivyspring International Publisher | 99.0% 4/433 Medicine (miscellaneous) | 40343 | 1686 |
| 27097 | Nanotheranostics | 13.7 | Q1 | Ivyspring International Publisher | 96.0% 2/46 Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 1758 | 128 |
| 27098 | Biologics | 7.2 | Q1 | Multidisciplinary Digital Publishing Institute (MDPI) | 93.0% 3/38 Immunology and Microbiology (miscellaneous) | 623 | 86 |
| 27099 | Marine Drugs | 10.1 | Q1 | Multidisciplinary Digital Publishing Institute (MDPI) | 92.0% 4/46 Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 27173 | 2681 |
| 27100 | Stresses | 6.9 | Q1 | Multidisciplinary Digital Publishing Institute (MDPI) | 91.0% 19/231 Agricultural and Biological Sciences (miscellaneous) | 1204 | 174 |
| 27101 | Frontiers in Toxicology | 6.2 | Q1 | Frontiers Media S.A. | 85.0% 7/46 Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 2302 | 374 |
| 27102 | Addictive Behaviors Reports | 5.7 | Q1 | Elsevier | 83.0% 8/46 Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 1286 | 227 |
| 27103 | Patient Preference and Adherence | 3.9 | Q1 | Dove Medical Press | 81.0% 9/46 Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 4060 | 1042 |
| 27104 | Science and Technology Indonesia | 2.3 | Q1 | Magister Program of Material Sciences, Graduate School of Sriwijaya University | 76.0% 97/414 General Mathematics | 680 | 300 |
| 27105 | Forensic Sciences | 2.9 | Q1 | Multidisciplinary Digital Publishing Institute (MDPI) | 75.0% 12/46 Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 481 | 167 |
| 27106 | Pharmaceutical Science Advances | 2.3 | Q2 | Elsevier | 66.0% 16/46 Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 99 | 44 |
| 27107 | Frontiers in Drug Safety and Regulation | 2.1 | Q2 | Frontiers Media S.A. | 64.0% 17/46 Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 116 | 54 |
| 27108 | Cancer Innovation | 2 | Q2 | John Wiley & Sons | 61.0% 18/46 Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 230 | 115 |
| 27109 | Vitae | 1.9 | Q2 | Universidad de Antioquia | 57.0% 20/46 Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 105 | 56 |
| 27110 | Dilemas | 1 | Q3 | Universidade Federal do Rio de Janeiro | 47.0% 585/1105 Law | 180 | 189 |
| 27111 | Open Access Journal of Clinical Trials | 1.1 | Q3 | Dove Medical Press | 44.0% 26/46 Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 16 | 14 |
| 27112 | Uspehi Molekularnoj Onkologii | 0.5 | Q3 | ABV-press Publishing house | 27.0% 34/46 Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 75 | 144 |
| 27113 | Farmacja Polska | 0.3 | Q4 | Polish Pharmaceutical Society | 16.0% 39/46 Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 95 | 278 |
| 27114 | Journal of Applied Pharmaceutical Research | 0.3 | Q4 | Creative Pharma Assent | 11.0% 41/46 Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 34 | 128 |
| 27115 | Journal of Pharmaceutical Investigation | 10.6 | Q1 | Springer Nature | 94.0% 3/46 Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 2077 | 196 |
| 27116 | Therapeutic Innovation and Regulatory Science | 3.8 | Q1 | Springer Nature | 79.0% 10/46 Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 1666 | 433 |
| 27117 | Value in Health Regional Issues | 3 | Q1 | Elsevier | 77.0% 11/46 Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 1051 | 355 |
| 27118 | International Journal of Pharmacy Practice | 2.8 | Q2 | Oxford University Press | 73.0% 13/47 Pharmacy | 857 | 311 |
| 27119 | Iranian Journal of Medical Sciences | 2.8 | Q2 | Shiraz University of Medical Sciences | 72.0% 13/46 Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 736 | 262 |
| 27120 | Research Results in Biomedicine | 1.9 | Q2 | Belgorod State National Research University | 59.0% 19/46 Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 302 | 160 |